H. Res. 362 is a simple House resolution that asks Congress to designate April 30, 2025, as "National Adult Hepatitis B Vaccination Awareness Day." It compiles public‑health findings about hepatitis B prevalence, infectiousness, and the availability of a safe, effective vaccine, then calls for expanded adult testing, vaccination of susceptible adults, and linkage to care for those diagnosed.
Though hortatory rather than statutory, the resolution matters because it signals congressional attention to adult vaccination gaps and frames a federal public‑health narrative that domestic health agencies, state and local departments, community providers, and advocacy groups can cite when planning outreach, education, and short‑term campaigns around the designated date.
At a Glance
What It Does
H. Res. 362 is a non‑binding resolution that designates a national awareness day, recites public‑health findings about hepatitis B, and urges increased adult testing, vaccination for susceptible adults, and linkage to medical care. It does not create new legal obligations or provide funding.
Who It Affects
Public health agencies, community clinics, harm‑reduction programs, health advocacy groups, and health systems that run vaccination and outreach activities are the primary audiences likely to use the designation. Federal agencies may face informal pressure to incorporate the day into outreach messaging.
Why It Matters
Even without legal force, congressional resolutions can catalyze awareness campaigns, inform grant proposals, and provide public legitimacy for coordinated outreach—particularly where adult vaccine uptake is low and targeted outreach could reduce future clinical burden.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
H. Res. 362 compiles a series of factual findings—about hepatitis B transmission, groups disproportionately affected, the availability and effectiveness of vaccines, and gaps in adult vaccine coverage—and then asks the House to recognize April 30, 2025 as an awareness day focused on adult hepatitis B vaccination.
The resolution is framed as a public‑health encouragement addressed to the public, providers, and community organizations rather than as a directive to any government entity.
Because the text contains no appropriations or regulatory language, its practical value lies in advocacy and coordination. States, local health departments, federally qualified health centers, and nonprofit groups can leverage the congressional designation when seeking local partners, mobilizing volunteers, timing clinic events, or applying for short‑term grants.
Private employers and healthcare systems may also use the date for internal campaigns to increase adult vaccination and testing among employees and patients.The resolution explicitly emphasizes three operational goals—encouraging at least one lifetime hepatitis B test for adults, promoting vaccination for susceptible adults, and linking diagnosed individuals to care. It leaves implementation details to existing public‑health channels, which means success will depend on how well those channels coordinate messaging, secure vaccine supply, and measure uptake around the awareness day.Finally, while symbolic, the resolution can influence communications between federal agencies and local partners: agencies may amplify the date via guidance and social media, and grantees may cite congressional support in community outreach.
However, because the resolution does not allocate resources, stakeholders will need to identify funding and operational partners if they intend to build sustained programs from the awareness effort.
The Five Things You Need to Know
The resolution designates April 30, 2025 as "National Adult Hepatitis B Vaccination Awareness Day.", It explicitly recognizes CDC recommendations that adults be tested for hepatitis B at least once in their lifetime.
The text urges vaccination for adults susceptible to hepatitis B and highlights the importance of linking diagnosed individuals to medical care.
H. Res. 362 contains no funding, no regulatory changes, and imposes no legal mandates on federal or state agencies.
The bill was introduced by Representative Henry Johnson (GA) and was referred to the House Committee on Energy and Commerce.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Factual findings on hepatitis B and vaccination
The preamble aggregates statistics and public‑health findings—on chronic infection prevalence, transmission pathways, affected populations, morbidity from liver disease, and existing vaccine effectiveness—to provide the factual basis for the resolution. Practically, these clauses are intended to justify the awareness day by documenting a public‑health gap; they do not create duties but supply talking points stakeholders can reuse in outreach materials.
Designation of the awareness day
This clause declares April 30, 2025 to be "National Adult Hepatitis B Vaccination Awareness Day." Legally, a House resolution like this is hortatory—it expresses the sense of the House but does not change statutes or authorize spending. Its immediate effect is symbolic recognition that advocates and agencies can reference when scheduling observances and campaigns.
Encouragements on testing, vaccination, and linkage to care
This paragraph lays out three discrete areas for action—testing adults at least once, vaccinating susceptible individuals, and linking diagnosed people to care. The provision signals congressional support for these public‑health practices, which may influence messaging and program priorities among health departments and community providers even though it imposes no reporting or operational requirements.
Call to increase vaccination, maintain childhood coverage, and raise awareness
The final resolve urges a commitment to raising adult vaccination rates, maintaining childhood vaccination, and promoting provider and community awareness. The clause effectively functions as a public endorsement that stakeholders can cite in grant applications, press releases, and internal policy memos; it also creates an expectation that existing prevention infrastructure could be mobilized around the designated date.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- State and local health departments — They can use the congressional designation to justify targeted outreach campaigns, solicit partners, and raise the profile of short‑term vaccination drives without needing new federal directives.
- Community health centers and Federally Qualified Health Centers (FQHCs) — The awareness day provides a public hook to run clinics, secure volunteer support, and boost adult vaccination appointments and testing events.
- Harm‑reduction and syringe‑service programs — The resolution's emphasis on adult vaccination and the drug‑use epidemic gives these programs additional backing to offer on‑site vaccination and testing, potentially improving reach among people who inject drugs.
- Patient advocacy and community organizations representing disproportionately affected groups — They gain a federally recognized date to coordinate culturally tailored outreach and to press for resources and partnerships.
- Healthcare payers and systems — Insurers and health systems may leverage the awareness day to promote preventive services, which can reduce long‑term costs associated with liver disease.
Who Bears the Cost
- State and local public‑health agencies — Expectations to run campaigns or clinics around the awareness day may require staff time, vaccine procurement, and outreach costs, typically funded out of existing budgets.
- Community clinics and FQHCs — Increased demand for vaccination and testing can strain appointment capacity and require operational adjustments (extended hours, mobile clinics) without guaranteed new funding.
- Federal agencies with public‑health communications roles — Agencies like CDC may face pressure to produce materials and amplify the day, consuming communications resources that are currently allocated elsewhere.
- Nonprofit organizations and advocacy groups — To capitalize on the designation, these groups may need to divert limited funding to campaign activities, potentially reducing resources for other services.
- Insurers and billing systems — A short‑term increase in adult vaccinations could raise administrative workload (claims processing, prior authorizations for at‑risk populations) even if vaccinations are recommended preventive services.
Key Issues
The Core Tension
The central dilemma is symbolic versus structural action: the resolution rightly draws attention to preventable adult hepatitis B infections, but by offering only a symbolic designation with no funding or enforcement it risks creating expectations that cannot be met without additional resources or operational commitments—forcing stakeholders to choose between sincere outreach with limited reach or deferring action pending concrete funding.
The most immediate limitation of H. Res. 362 is its lack of binding force and its absence of appropriations.
The resolution can legitimize and coordinate messaging, but it does not address the practical constraints that limit adult vaccine uptake—reimbursement structures, clinic capacity, transportation barriers, and vaccine hesitancy. That creates a risk that public expectations will outpace the resources available to meet them: communities may be urged to act without a clear, funded operational plan.
Measurement and accountability are also unresolved. The resolution urges increased vaccination and testing but sets no performance metrics or reporting pathways.
Stakeholders who want to assess impact will need to rely on existing surveillance systems and ad hoc data collection tied to clinics or programs, which vary in timeliness and completeness. There is additionally a communication trade‑off: targeted messaging toward high‑risk groups can improve efficiency but risks stigmatizing communities; universal adult messaging avoids stigma but dilutes focus where the burden is highest.
Finally, jurisdictional dynamics matter—public health authority primarily rests with states and localities, so the federal designation works best when it complements state plans rather than substitutes for operational funding or regulatory action.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.